logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Eli Lilly & Co.

Eli Lilly & Co. (LLY)

Follow

Details

Wall

Profile


Eli Lilly and Company is a drug manufacturing company. It discovers, develops, manufactures, and sells products in two business segments: human pharmaceutical products and animal health products.

Issuer Information

Exchange: NYSE
Market Cap: 61442662246
CEO: John C Lechleiter
Employees: 38350
Issuer Type: CS
Auditor: Ernst & Young LLP
Last Audit: UQ
CIK: 59478
Sector: Healthcare
Industry: Drug Manufacturers
Sub-Industry: Drug Manufacturers - Major
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: 2834
Last earning call url:
Slideshare slide url:

Contact Information

Main phone: +1 317 276-2000
Address: Lilly Corporate Center
Address 2: Drop Code 1112
State: IN
City / Town: Indianapolis
Country:
Postal Code: 46285
Fax:

Videos

No public videos available.

Blog

No Result Found.

News

One of the S&P 500’s big winners for Thursday December 18 was Eli Lilly & Co. ($LLY) as the company’s stock climbed 3.09% to $72.45 on volume of 5.81 million…
One of the S&P 500’s big losers for Friday December 12 was Eli Lilly & Co. (LLY) . The company’s stock fell 2.88% to $69.55 on volume of 7.7 million…
One of the S&P 500’s big winners for Tuesday December 02 was Eli Lilly & Co. (LLY) as the company’s stock climbed 2.73% to $70.38 on volume of 8.22 million…
Pfenex ($PFNX) was a December 2009 spinout from The Dow Chemical Company (DOW) headquartered in San Diego, CA, Eleven other companies are scheduled for the week of July 14, 2014. The…
Ambrx ($AMBX) is a clinical stage biotechnology company focused on discovering and developing first-in-class and best-in-class optimized protein therapeutics known as bio-conjugates. It is headquartered in La Jolla, CA. Fourteen other…
Billions of dollars have been spent chasing molecular targets in neurological diseases that now appear to be worthless. Effective therapies remain rare. But the market is enormous—and low risk—if a…
Shares of small-cap pharma Ariad Pharmaceuticals (ARIA) were trading higher on Friday after rumors were started by British paper The Daily Mail that Jazz Pharmaceuticals (JAZZ) was interested in acquiring…
Shares for biotech firms fell late in Friday’s trading session, throwing a damper on the strong buying that had characterized the day’s activity prior to 2pm. Stocks held on to…
Starting a new investment company and investing in very small biotechs can be a minefield. Because the business is fraught with bad science and liquidity traps, it takes insight and…
Wall Street closed lower today after a fairly brutal sell-off that kept all benchmark indices in the red for the entirety of the trading session, after what has been an…

Followers

No followers yet

Trending

Social Mentions about your company in the last seven days
The Legacy News
22 Dec 14 17:14:01
Traders Buy Eli Lilly and on Weakness $LLY http://t.co/p4JwwSA4Iy
ProVesting
22 Dec 14 17:04:09
$LLY: Traders Buy Eli Lilly and on Weakness (LLY) http://t.co/gFHHgoIOWA http://t.co/5929qeo6rk
FinSentS SP500
22 Dec 14 15:17:49
$LLY:US Eli Lilly and PT Raised to $76.00 at Leerink Swann (NYSE:LLY) #LILLY (ELI) & CO http://t.co/THY9lyQivK #SP500
Patrick
22 Dec 14 14:35:26
RT @lomu_j: $ALDR not too affected by today's pricing war news. CGRP migraine competition from $TEVA $LLY and $AMGN
iSENTIUM
22 Dec 14 14:17:53
iSENTIUM Post-Market Sentiment Report: Breaking alerts on $LLY, $MDT, $OCN, $ASPS http://t.co/9tab30AsvX
j l
22 Dec 14 14:14:27
$ALDR not too affected by today's pricing war news. CGRP migraine competition from $TEVA $LLY and $AMGN
Bilo Selhi
22 Dec 14 13:34:08
Subscribers alerted to $APT +23% http://t.co/T9zutL79nE SEE TRACK RECORD http://t.co/vqljuIo00m $MET $GM $UPS $DAL $F $FL $LLY $TWTR
Thudder & Wicks
22 Dec 14 13:08:18
Deals of the Day: $APP takeover offer far too low, $GS, $LLY, $BCS, CNP Assurances http://t.co/x190XyhbQk
StockNewsWires
22 Dec 14 11:53:02
$LLY $BIIB: Roche Loses A Little Luster Before Year-End http://t.co/SbEGqiOFjU http://t.co/WgRCxE53jx
ProTradersNews
22 Dec 14 11:33:02
$LLY: Lilly Signs Agreement With British University http://t.co/N1anMcLvmx http://t.co/dtOubEyBrv
4-traders.com
22 Dec 14 11:14:10
#Eli Lilly : to sell heartworm line for Novartis deal approval http://t.co/zIeUh7HScV $LLY
Business BioTech
22 Dec 14 09:53:13
RT @Sachakin: RT @JohnCFierce EuroBiotech : Eli Lilly rekindles Adocia partnership.. $LLY $ADOC http://t.co/GhWYqMuonT
MarketCurrents
22 Dec 14 09:32:16
Lilly jettisons Sentinel line as a condition for clearance of Novartis deal http://t.co/zZFLhzRttf $LLY $NVS
Briefing.com
22 Dec 14 09:02:47
$LLY: Eli Lilly announces a five-year research partnership with the University of Surrey to study health outcomes,... http://t.co/euTu0gt0nw
4-traders.com
22 Dec 14 08:58:12
#Lilly must divest Sentinel products after FTC nod on Novartis deal http://t.co/ZwaVlwBbXW $LLY
ProTradersNews
22 Dec 14 08:48:06
$LLY: Eli Lilly receives marketing authorization from the European ... http://t.co/LxUyV7eSMT http://t.co/XH8kxMGNzo
Market Int Center
22 Dec 14 08:02:39
Eli Lilly $LLY Trading Near $70.80 Support Level ( http://t.co/NsaOFVDBBs )
SogoTrade
22 Dec 14 08:00:44
Just released! SogoTrade’s Morning Call on Today’s Spotlight Stocks $TXN, $BXP, $EWJ, $IGE, $LLY, $CVX, $YGE... http://t.co/W7Jv1MSNbf
NASDAQ
22 Dec 14 07:20:11
$LLY - Lilly Announces Diabetes Research Partnership with University of Surrey http://t.co/BGzbVXF2dZ
Analyst Ratings
22 Dec 14 07:16:38
Leerink Swann Believes this Stock Still Has Room to Grow $LLY http://t.co/jMMcSQDKlN
ProVesting
22 Dec 14 07:09:07
$LLY: Lilly Announces Diabetes Research Partnership with University of ... http://t.co/RQEasyn4jX http://t.co/yQAiNYyQpv
Breaking News
22 Dec 14 07:06:26
$LLY Lilly Announces Diabetes Research Partnership with University of Surrey http://t.co/xAn4a4s76J
$Stocknewsalerts
22 Dec 14 07:04:52
$LLY Lilly Announces Diabetes Research Partnership with University of Surrey From our Stock News Alerts App
NASDAQ
22 Dec 14 07:04:49
$LLY - Lilly Announces Diabetes Research Partnership with University of Surrey http://t.co/kfGbNEKa4O
NASDAQ
22 Dec 14 07:04:47
$LLY - Lilly Announces Diabetes Research Partnership with University of Surrey http://t.co/avRmIYq699
4-traders.com
22 Dec 14 07:02:10
#Eli Lilly : Lilly Announces Diabetes Research Partnership with University of ... http://t.co/GkCPah2Yxr $LLY
Julie-Anne Webb
22 Dec 14 07:01:28
RT @fwpharma: ViewPoints: Adocia revives diabetes collaboration with Eli Lilly http://t.co/xtx7TPkwDI $LLY #pharma
The GMP Group
22 Dec 14 07:00:37
RT @fwpharma: ViewPoints: Adocia revives diabetes collaboration with Eli Lilly http://t.co/xtx7TPkwDI $LLY #pharma
FirstWord Pharma
22 Dec 14 07:00:25
ViewPoints: Adocia revives diabetes collaboration with Eli Lilly http://t.co/xtx7TPkwDI $LLY #pharma
Fun VA capital
22 Dec 14 06:44:57
Ignore the Dow, trade on the merits of the stock in hand $WFC $hpq $bac $hal $lly $mc $v $gsch
Media Sentiment
22 Dec 14 06:00:13
$LLY received a new alert. Find out why at http://t.co/5lwmDm2SCs #stocks #daytrading #trading #mkt #NYSE #NASDAQ #markets 83
US Consumer News
22 Dec 14 05:59:51
Eli Lilly and's PT raised by Leerink Swann to $76.00. outperform rating. http://t.co/IPX8KfPsqS $LLY #LLY
Joe
22 Dec 14 05:59:37
@SnupSnus @Sport234a Leerink up'ed PT from $67 to $76 today. $LLY
ApricusIR
22 Dec 14 05:57:49
Apricus: "market for ED treatments in Europe represents approximately $1.3 billion in annual sales" http://t.co/kYlJyVNSd7 $APRI $PFE $LLY
Analyst Ratings
22 Dec 14 05:55:11
Eli Lilly and's PT raised by Leerink Swann to $76.00. outperform rating. http://t.co/bmiTIChrLY $LLY #LLY
ProVesting
22 Dec 14 05:28:06
$RDUS $LLY: Radius Health osteoporosis drug candidate successful in Phase 3 trial http://t.co/zk8eZiNPIx http://t.co/cMzwpQOMUY
MarketCurrents
22 Dec 14 05:23:24
Radius Health osteoporosis drug candidate successful in Phase 3 trial http://t.co/Q34VV8F8MN #premarket $RDUS $LLY
ProTradersNews
22 Dec 14 04:48:03
$CDE $LLY $UTIW: Momentum Stocks: Coeur Mining, Inc. (NYSE:CDE), Eli Lilly and ... http://t.co/cL0xHjwMXu http://t.co/F6zLYoBI54
Ronald J. Perez, PhD
22 Dec 14 04:11:07
RT @fwpharma: ICYMI: Eli Lilly gains rights to Adocia's experimental ultra-rapid insulin under potential $570-million deal http://t.co/lCwl…
The GMP Group
22 Dec 14 03:52:30
RT @fwpharma: ICYMI: Eli Lilly gains rights to Adocia's experimental ultra-rapid insulin under potential $570-million deal http://t.co/lCwl…
FirstWord Pharma
22 Dec 14 03:51:43
ICYMI: Eli Lilly gains rights to Adocia's experimental ultra-rapid insulin under potential $570-million deal http://t.co/lCwlUxt2OM $LLY
ProTradersNews
22 Dec 14 03:33:05
$LLY $EXAS: Eli Lilly (NYSE:LLY) Signs worldwide Licensing Partnership- Red ... http://t.co/DS5qnZTftb http://t.co/MZVTUMEXmU
Bilo Selhi
21 Dec 14 21:42:33
Subscribers alerted to $FOMX +17% http://t.co/T9zutL79nE SEE TRACK RECORD http://t.co/WryBemA3fj $MU $MET $UPS $LLY $TWTR $REGN $PNC $TXN
Me Likeitalot
21 Dec 14 08:56:48
RT @fezziwig2008: @CaesarBiotech With all due respect isn't $ADOC the Co. $LLY dropped? Big Pharma is flocking to $HALO
TalkMarkets Recap
21 Dec 14 08:03:36
Week In Review: China's #Neusoft Raises $610 Million For Life Science Subsidiaries $SCLN $MDCO $LLY $NBY http://t.co/AnzDSX33f3
Hammer D. Lane
21 Dec 14 07:46:21
$LLY Long,.....http://t.co/9WUvSFEQEt
ProTradersNews
21 Dec 14 07:28:03
$INCY $LLY: Big Movers: Sandstorm Gold (NYSEMKT:SAND), Incyte Corporation ... http://t.co/ZgyU7gtfou http://t.co/AHuLWmUMjo
ProVesting
21 Dec 14 06:06:03
$AZN $LLY $ESRX: Drug Giants Face $65 Billion in Lost Sales as Insurers Attack Patents http://t.co/PHtpN0qGpu http://t.co/3Gr14H8Bxk
fezziwig2008
21 Dec 14 06:02:26
@CaesarBiotech With all due respect isn't $ADOC the Co. $LLY dropped? Big Pharma is flocking to $HALO
TalkMarkets
21 Dec 14 02:11:53
Week In Review: China's #Neusoft Raises $610 Million For Life Science Subsidiaries $SCLN $MDCO $LLY $NBY http://t.co/gGRS4j70DO

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.